These findings indicate that patients with advanced stages of lung cancer and lymph node metastases demonstrate increased serum levels of miR-21, HSP-90α, and GASP-1. This evidence concerns the gene HSP90AA1 and metastatic malignant neoplasm in the lymph nodes.